MVIS US Listed Biotech 25 Index

The MVIS US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Components

The MVIS US Listed Biotech 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
10X GENOMICS INCUS1.62%
ALNYLAM PHARMACEUTICALS INCUS2.89%
AMGEN INCUS8.02%
BEIGENE LTD-ADRKY3.13%
BIO-TECHNE CORPUS4.05%
BIOGEN INCUS4.02%
BIOMARIN PHARMACEUTICAL INCUS2.25%
BIONTECH SEDE5.31%
CHARLES RIVER LABORATORIESUS3.93%
CRISPR THERAPEUTICS AGCH1.18%
EXACT SCIENCES CORPUS2.92%
GILEAD SCIENCES INCUS5.72%
GUARDANT HEALTH INCUS2.36%
ICON PLCIE5.23%
ILLUMINA INCUS4.38%
INCYTE CORPUS2.05%
INTELLIA THERAPEUTICS INCUS1.29%
IQVIA HOLDINGS INCUS5.57%
MODERNA INCUS11.19%
NATERA INCUS1.85%
NOVAVAX INCUS3.12%
QIAGEN NVNL2.82%
REGENERON PHARMACEUTICALSUS5.35%
SEAGEN INCUS4.30%
VERTEX PHARMACEUTICALS INCUS5.44%
Items 1-25 of total 25
Up